MicroOrganoSphere (MOS) Drug Screen Pilot Trial in Colorectal Cancer

NCT05189171 · clinicaltrials.gov ↗

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DEVICE: MicroOrganoSphere (MOS) drug screen

Sponsor

Xilis, Inc.